Marked: Copenhagen Symbol: CHR ISIN: DK0060227585
Chr. Hansen is a global bioscience company that develops natural solutions for the food, nutritional, pharmaceutical and agricultural industries. We develop and produce cultures, enzymes, probiotics and HMOs for a variety of foods, beverages, dietary supplements, animal feed and crop protection.
Aktieoplysninger 28-06-2022
Valuta DKK
Tidligere lukket 523,60
52 uger % -7,50
Mængde 184.073
Antal aktier 131.852.496
Markedsværdi (mil.) 69,0
Sidste lukkekurs Valuta 52 uger % Volume Antal aktier Markedsværdi (mia.)
523,60 DKK -7,50 184.073 131.852.496 69,0

Nøgletal, EUR mio

         
Resultatopgørelse (cont. operations) 2020/21 2019/20 2018/19 2017/18 2016/17
Omsætning 1.077,4 970,0 937,4 1.097,4 1.062,5
Bruttoresulta 613,4 584,0 576,9 600,6 578,1
EBITDA - før særlige poste 399,3 400,6 372,3 384,0 368,1
EBIT før særlige poster 298,1 326,9 314,7 320,2 307,1
EBIT 276,2 313,0 312,4 320,2 305,7
Finansielle poster, netto (22,5) (13,5) (16,1) (24,1) (14,8)
Profit from continuing operations 198,7 231,6 229,2 228,2 224,0
Profit from discontinued operations 646,5 13,4 21,0 - -
Årets resultat 845,2 245,0 250,2 228,2 224,0
           
Cash flow (Group) 2020/21 2019/20 2018/19 2017/18 2016/17
Pengestrøm fra driften 310,8 364,6 298,6 302,4 283,7
Cash flow from investing activities 284,5 (807,5) (81,6) (107,0) (176,5)
Frie pengestrømme 595,3 (442,9) 217,0 195,4 107,2
Frie pengestrømme før opkøb og særlige poster 183,9 244,5 229,1 195,9 187,8
Free cash flow before acquisitions and special items, cont. operations 196,4 224,9 220,2 - -
           
Balance (Group) 2020/21 2019/20 2018/19 2017/18 2016/17
Aktiver i alt ¹⁾ 3.114,2 2.853,6 2.057,8 1.861,1 1.802,1
Investeret kapital ¹⁾ 2.793,1 2.487,6 1.745,3 1.631,5 1.581,1
Nettodriftskapital ¹⁾ 190,1 208,1 220,6 189,1 174,8
Egenkapital 1.626,1 893,0 797,2 771,6 768,5
Nettorentebærende gæld 898,2 1.345,0 734,4 658,7 628,4
           
Nøgletal 2020/21 2019/20 2018/19 2017/18 2016/17
           
Continuing operations          
Organisk vækst, % 7 6 8 9 10
Bruttoavance, % 56,9 60,2 61,5 54,7 54,4
EBITDA margin før særlige poster, % 37,1 41,3 39,7 35,0 34,6
EBIT- før særlige poster, % 27,7 33,7 33,6 29,2 28,9
EBIT- margin, % 25,6 32,3 33,3 29,2 28,8
Afkast af gennemsnitlig investeret kapital ekskl. goodwill, % 24,8 33,6 39,2 38,0 40,1
Afkast af gennemsnitlig investeret kapital, % 11,6 16,8 20,3 19,9 20,3
Forskning og udvikling, % 8,5 8,0 8,1 7,3 7,0
Anlægsinvesteringer, % 14,5 12,2 12,6 9,8 10,0
EPS, fortsættende aktiviteter, udvandet 1,51 1,76 1,74 - -
Gennemsnitligt antal ansatte 3.398 2.932 2.768 3.151 2.940
           
Group          
EPS, fortsættende aktiviteter, udvandet 6,41 1,86 1,90 1,73 1,68
Nettorentebærende gæld/EBITDA 2,3x 3,1x 1,8x 1,7x 1,7x

Following the classification of the Natural Colors business as discontinued operations in 2019/20, the business is presented separately on an aggregated level in the income statement, balance sheet and cash flow statement. In accordance with IFRS, the income statement and the cash flow statement have both been restated in previous periods, while the balance sheet has not been restated in previous periods. The comparative figures for 2016/17 - 2017/18 have not been restated and are not directly comparable.

Numbers are not restated and therefore not directly comparable

¹⁾ The Natural Colors business was divested as of March 31, 2021. For the financial years 2016/17-2019/20, total assets, invested capital and net working capital include assets and liabilities related to the Natural Colors business.